Literature DB >> 12966064

An ubiquitin ligase recognizing a protein oxidized by iron: implications for the turnover of oxidatively damaged proteins.

Kazuhiro Iwai1.   

Abstract

Protein oxidation is a natural consequence of aerobic metabolism in cells. Oxidative modification of amino acid residues of proteins causes to lose activity or function of proteins. Organisms have thus developed pathways to remove oxidized proteins by rapid protein degradation. These pathways are important components in cellular quality control mechanisms. It has been suggested that oxidized proteins are degraded by the proteasome. However, whether ubiquitylation is necessary for the degradation of oxidized proteins remains a controversial issue. We have recently identified HOIL-1 (heme-oxidized IRP2 ubiquitin ligase-1) as an E3 ligase that recognizes a protein that has been oxidized by iron. This review describes the recent progress made in understanding the ubiquitin-proteolytic pathway and the regulation of iron metabolism. The process involved in eliminating oxidized proteins and the possible roles that HOIL-1 ubiquitin ligase may play in these processes are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966064     DOI: 10.1093/jb/mvg127

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

Review 1.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

2.  Role of acylamino acid-releasing enzyme/oxidized protein hydrolase in sustaining homeostasis of the cytoplasmic antioxidative system.

Authors:  Atsushi Nakai; Yasuo Yamauchi; Sawako Sumi; Kiyoshi Tanaka
Journal:  Planta       Date:  2012-03-08       Impact factor: 4.116

3.  Evaluation of serum iron levels during FOLFOX4 and FOLFIRI therapies.

Authors:  Satomi Mashiko; Isao Nagaoka; Masayuki Kitajima; Tomoo Watanabe; Kazuhiko Nishimura; Shunji Futagawa; Takumi Ochiai
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.